| Name | Title | Contact Details |
|---|---|---|
Fadel Hamed |
Vice President Cusomer Success | Profile |
Larry Meese |
Vice President, Product and Solutions | Profile |
The Command Group Inc. is a Wexford, PA-based company in the Computers & Electronics sector.
LANScapes is a Woodstock, GA-based company in the Computers and Electronics sector.
Cloud Imperium is an international independent game company. We`re currently developing Star Citizen, a record-shattering crowd-funded title that combines classic space sim gameplay with amazing visuals; and Squadron 42, a Hollywood-caliber story-driven single-player game set in Star Citizen’s universe.
SoftwareONE is a leading global provider of end-to-end software and cloud technology solutions, headquartered in Switzerland. With an IP and technology-driven services portfolio, it enables companies to holistically develop and implement their commercial, technology and digital transformation strategies. This is achieved by modernizing applications and migrating critical workloads to public clouds, while simultaneously managing and optimizing the related software and cloud assets and licenses. SoftwareONE`s offerings are connected by PyraCloud, its proprietary digital platform, which provides customers with data-driven, actionable intelligence. With around 7,700 employees and sales and service delivery capabilities in 90 countries, SoftwareONE provides around 65,000 business customers with software and cloud solutions from over 7,500 publishers. SoftwareONE`s shares (SWON) are listed on SIX Swiss Exchange.
Cota is a technology platform that enables providers, payers, and life science companies involved in diagnosing and treating complex diseases to optimize the care of individual patients and lower the overall cost of the patient population served. It is powered by the patented Cota Nodal Address™ (CNA) system, a unique digital classification methodology built by leading physicians and data scientists. The CNA is the first and only system that precisely categorizes patient factors, their diseases and intended therapies, enabling precision medicine at scale.